Abstract Experimental and clinical studies suggest that gliclazide may protect pancreatic b-cells from apoptosis induced by an oxidative stress. However, the precise mechanism(s) of this action are not fully understood and requires further clarification. Therefore, using human normal and cancer cells we examined whether the anti-apoptotic effects of this sulfonylurea is due to its free radical scavenger properties. Hydrogen peroxide (H 2 O 2 ) as a model trigger of oxidative stress was used to induce cell death. Our experiments were performed on human normal cell line (human umbilical vein endothelial cell line, HUVEC-c) and human cancer cell lines (human mammary gland cell line, Hs578T; human pancreatic duct epithelioid carcinoma cell line, PANC-1). To assess the effect of gliclazide the cells were pretreated with the drug. The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay was employed to measure the impact of gliclazide on cell viability. Generation of reactive oxygen species, mitochondrial membrane potential (DW m ), and intracellular Ca 2? concentration [Ca 2? ] were monitored. Furthermore, the morphological changes associated with apoptosis were determined using double staining with Hoechst 33258-propidium iodide (PI). Gliclazide protects the tested cells from H 2 O 2 -induced cell death most likely throughout the inhibition of ROS production. Moreover, the drug restored loss of DW m and diminished intracellular [Ca ] evoked by H 2 O 2 . Double staining with Hoechst 33258-PI revealed that pre-treatment with gliclazide diminished the number of apoptotic cells. Our findings indicate that gliclazide may protect both normal and cancer human cells against apoptosis induced by H 2 O 2 . It appears that the anti-apoptotic effect of the drug is most likely associated with reduction of oxidative stress.
Introduction
Prospective clinical studies and autopsy studies show significant reduction of b-cell function and mass, respectively, in people with type 2 diabetes mellitus (T2DM) [1] . Several factors including hyperglycemia, hyperinsulinemia, hyperlipidemia, low-grade inflammation, and deposition of islet amyloid polypeptide in human pancreas have been proposed to account for this defect in T2DM [2] [3] [4] . Chronic hyperglycemia leads to an increased generation of reactive oxygen species (ROS), oxidative stress, and endoplasmic reticulum stress in a variety of cells. In comparison with many other cell types, the b-cells may be at exceptionally high risk of oxidative damage and an increased sensitivity for apoptosis [5, 6] .
Apart from a fundamental role of mitochondrial electron transport chain in ROS overproduction, additional sources of ROS may increase oxidative stress in diabetes including glucose autoxidation, protein kinase C activation, methylglyoxal formation and glycation, hexosamine metabolism, and sorbitol formation [2, 4, 7, 8] . Recently published data indicate, that excessive concentration of ROS in diabetes is responsible for the activation of several intracellular signalling pathways, that may affect cell function and structure, increasing the risk of apoptosis [5, 6] .
Gliclazide-a second-generation sulphonylurea-is commonly used for the treatment of T2DM. The drug act by stimulating insulin release from the pancreatic b-cells to lower blood glucose. The insulin secretion is triggered by binding of gliclazide to a specific K ? sulfonylurea receptor subtype of ATP-sensitive potassium channels at the level of b-cells plasma membrane (sulfonylurea receptor 1, SUR1), which leads to its closure and subsequent opening of the calcium channels and activation of an effector system of insulin release [9] . The binding of gliclazide to SUR1 is rapidly reversible in contrast to other sulphonylureas (e.g. glibenclamide), that exhibit prolonged binding to SUR1. Besides its hypoglycemic effect, gliclazide has been found to possess extra -pancreatic and antioxidant properties. It appears, that antioxidant activities are independent of any influence on glycemic control [10, 11] .
It is of concern, that the long-term use of sulphonylureas, especially glibenclamide, may cause b-cells dysfunction and apoptosis [1] . However, the mechanism(s) of this serious, unwanted effect is unclear and several explanations have been proposed. One of them is an oxidative stress that in people with T2DM is not only related to chronic hyperglycemia but, it is also suggested that insulin secretagogues may directly increase ROS generation and cause an oxidative stress related in b-cell apoptosis [12] . As a consequence of ROS overproduction and its damaging action, b-cell mass and secretory function in T2DM patients treated with sulfonylurea may progressively decline. Insufficient level of insulin in the circulation is responsible for uncontroled hyperglycemia and hyperlipidemia, which in turn cause b-cell damage and induce apoptosis [13, 14] . According to Rustenberg et al. this situation may create a vicious circle, with the improvement of metabolic control being achieved at the expense of an accelerated loss of beta cell mass [8] .
Interestingly enough, it has recently been found that gliclazide prevented mice, rat and human pancreatic b-cells and human endothelial cells from apoptosis [15] [16] [17] [18] [19] . It is suggested that this action of the drug is most likely associated with its free radical scavenging properties [20] . However, anti-apoptotic action of gliclazide in other types of cells, especially cancer cells, has not been explored sufficiently. Therefore, the aim of our study was to check whether gliclazide has also ability to prevent human normal (HUVEC-c) and two cancer cell lines (PANC-1 and Hs578T) from apoptosis induced by an oxidative stress. The HUVEC-c cell line as a one of type of human normal endothelial cells has not been explored for this purpose. We believe that PANC-1 and Hs578T cell lines are good candidates for our study as examples of the most common T2DM associated cancers. 
Materials and methods

Chemicals
Cell culture and treatment
The normal cell line (human umbilical vein endothelial cell line-HUVEC-c), and cancer cell lines (pancreatic duct epithelioid carcinoma cell line-PANC-1 and mammary gland cell line-Hs578T) were purchased from ATCC. PANC-1 cell strain is derived from an epithelioid carcinoma of pancreatic duct of 56 year old Caucasian male. Chromosome studies indicate a modal number of 63 with 3 distinct marker chromosomes and a small ring chromosome. This is a hypertriploid cell line. The Hs 578T cell strain is derived from the breast carcinoma of 74 year old Caucasian female. Cytogenetic analysis revealed that Hs578T cell line is a hypotriploid with a modal chromosome number of 59. This cell line does not express estrogen receptor. All cell lines were grown as a monolayer in standard conditions: 37°C, 100% humidity, the atmosphere being 5% CO 2 and 95% air with appropriate growth medium: (1) HUVEC-c cell line-F-12K medium supplemented with 0.1 mg/ml heparin and 0.05 mg/ml endothelial cell growth supplement, (2) PANC-1 cell line-DMEM, and (3) Hs578T cell line-DMEM supplemented with 0.01 mg/ml bovine insulin. Complete growth media were supplemented with 10% fetal bovine serum, penicillin (10 U/ml) and streptomycin (50 lg/ml). In all experiments cells in logarithmic phase of growth were used. The cells were monitored periodically for mycoplasma contamination. Cultured cells were removed by trypsinization, resuspended in fresh medium, centrifuged for 5 min at 2009g and plated into 96-well plates at the density of 10 5 cells/ml (10 4 cells/well) for 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), ROS, mitochondrial membrane potential assays or on petri dishes for morphological examination and at the density of 3 9 10 4 cells for calcium assay according to the manufacture's protocol. After 24 h (time necessary to ensure, that the cells were in the exponential growth phase) different concentrations of H 2 O 2 were added to the appropriate microplate wells or Petri dishes and the cells were incubated in a CO 2 incubator for different period of time (2-72 h) depending on the assessment method.
In some experiments cells were pre-incubated with the 3 mM N-acetylcysteine (NAC) or different concentrations of gliclazide (5-50 lM) for 1 h, then H 2 O 2 at the appropriate subtoxic concentration (50, 100, 200 lM) was added and incubation was continued for the required period of time under the same conditions. After pre-treatment with NAC or gliclazide the media were replaced with fresh ones without NAC or gliclazide. Control cells were treated with a corresponding volume of medium (instead of H 2 O 2 or antioxidants) according to the same schedule. NAC was used as a control agent for gliclazide.
Cytotoxicity assays
The cytotoxicity of H 2 O 2 in human tumor and normal cell lines was measured by a standard microplate MTT colorimetric method [21] . For this purpose 10 4 cells in 0.1 ml culture medium were seeded to each well. After 24 h, 0.05 ml H 2 O 2 in different concentrations (50-600 lM) was added to appropriate wells, and cells were incubated for 24, 48 or 72 h. After incubation, 50 ll MTT at the final concentration of 6 9 10 -3 M in PBS was added to each well and the microplates were incubated in a CO 2 incubator for 3 h. After aspiration of the culture medium, the obtained formazan crystals were dissolved in 100 ll dimethyl sulfoxide (DMSO), the plates were mechanically agitated for 1 min, and absorbance at 570 nm was measured with a microplate reader (Awareness Technology Inc., USA). Cytotoxicity of the H 2 O 2 was expressed as IC 50 value, which is the concentration of compound that reduces cell viability by 50% relative to the control (untreated cells).
In the experiments with antioxidant, the cells were preincubated with NAC (3 mM) or gliclazide (5-50 lM) and then treated with 50, 100 or 200 lM of H 2 O 2 for 24, 48 or 72 h. The relative number of viable cells was determined by comparing the absorbance of the treated cells with the corresponding absorbance of untreated (control) cells taken as 100%.
Determination of ROS level
Intracellular ROS production was determined directly in cell monolayers in black 96-well flat-bottom microtiter plates using a Fluoroskan Ascent FL microplate reader (Labsystems, Sweden). Cells in complete medium were incubated with 50-200 lM of H 2 O 2 for 2, 4 or 24 h in the presence or absence of the antioxidants (3 mM NAC, gliclazide: 5-50 lM). To measure the production of ROS, cells were treated with 5 lM DCFH2-DA at 37°C for 30 min and the fluorescence of DCF was measured at 530 nm after excitation at 485 nm (DCFH2-DA after deacetylation to DCFH2 is oxidized intracellularly to its fluorescent derivative DCF). Assays were performed in modified Hank's buffered salt solution (HBSS) (140 mM NaCl, 5 mM KCl, 0.8 mM MgCl 2 , 1.8 mM CaCl 2 , 1 mM Na 2 HPO 4 , 10 mM HEPES and 1% glucose, pH 7.0).
Mitochondrial membrane potential (DW m )
Cells were seeded in 0.1 ml culture medium into black 96-well titration microplates. After 24 h, 0.05 ml H 2 O 2 (50-200 lM) or an uncoupling mitochondrial agent chlorophenylhydrazone (CCCP) in various concentrations (0.01-10 lM) was added to appropriate wells. The cells were incubated with H 2 O 2 and CCCP for 2, 4 or 24 h. At the end of H 2 O 2 or CCCP treatment, the medium was removed and the cells were incubated with 5 lM JC-1 in HBSS for 30 min, at 37°C, in the dark. Then the fluorescence of both JC-1 monomers and dimers was measured on a Fluoroskan Ascent FL microplate reader (Labsystems, Sweden) using filter pairs of 530 nm/590 nm (dimers) and 485 nm/538 nm (monomers). JC-1 is a fluorescent carbocyanine dye, which accumulates in the mitochondrial membrane in two forms (monomers or dimers), depending on mitochondrial membrane potential. JC-1 monomers show maximum fluorescence excitation and emission at 485 and 538 nm wavelengths, respectively. Negative potential of the inner mitochondrial membrane facilitates the formation of dye aggregates, which results in the shift of JC-1 monomer fluorescence towards red light (from k ex = 530 nm to k em = 590 nm) [22] . Thus, the measurement of the JC-1 dimer to monomer fluorescence ratio is a convenient and reliable method for estimation of changes in mitochondrial membrane potential. Prior to fluorescence measurements and taking pictures, the cells were washed twice with HBSS to remove the dye, which could be adsorbed into the microplate well plastic and disturb the measurements. The results in the figures are shown as a ratio of dimer to monomer fluorescence in relation to the control fluorescence ratio, assumed to be 100%. As a positive control for the dissipation of DW m , cells were incubated with an uncoupling mitochondrial agent CCCP.
The cells presented in the pictures in Fig. 5 were preincubated with 25 lM gliclazide or 3 mM NAC for 1 h, then H 2 O 2 (200 lM) was added and incubation was continued for the next 4 h. JC-1 fluorescence was photographed immediately after drug treatment.
Monitoring of apoptosis and necrosis
The appearance of apoptotic and necrotic cells was monitored by double staining with Hoechst 33258 and propidium iodide using a fluorescence microscopy (Olympus IX70, Japan; magnification 4009). After 24, 48 or 72 h treatment of cells with 200 lM of H 2 O 2 , the cells were removed from the culture dishes by trypsinization, centrifuged and suspended in PBS at the concentration 10 6 cells/ ml. 1 ll Hoechst 33258 (0.13 mM) and 1 ll PI (0.23 mM) were added to 100 ll of cell suspension. After 10 min of incubation at room temperature in the dark, the cells were dropped onto microscopic slides and examined. When antioxidants were included the cells were firstly incubated with 3 mM NAC or 25 lM gliclazide for 1 h, and then with a H 2 O 2 for additional 24, 48 or 72 h. The cells were classified on the basis of their morphological and staining characteristics as: live (mate blue fluorescence), early apoptotic cells (intensive bright blue fluorescence), late apoptotic cells (blue-violet fluorescence) and necrotic (red fluorescence) [23] . Representative areas of cells stained at 48 h of were chosen for documentation.
Intracellular calcium measurement
Control and H 2 O 2 treated cells were seeded into a 96-well plate (3 9 10 4 cells in 0.2 ml culture medium per well). After 24 h the cells were treated with H 2 O 2 (50-200 lM) for 4, 24, 48 or 72 h. In experiments with antioxidants, cells were preincubated with 3 mM NAC or 5-50 lM gliclazide for 1 h, then H 2 O 2 was added and incubation was continued for another 4, 24, 48 or 72 h. At the end of incubations the medium was removed in order to eliminate sources of baseline fluorescence (the cells were washed twice with PBS). Subsequently cells were incubated with dye loading solution (Fluo-4 NW dye, probenecid, assay buffer-19 HBSS, 20 mM HEPES), which were processed according to the Fluo-4 NW Calcium Assay Kit protocol supplied by the manufacturer (Molecular Probes) and incubated for 30 min in the dark at 37°C, and then for another 30 min at the room temperature. The measurement was done on Fluoroskan Ascent FL microplate reader (Labsystems, Sweden) using 494 nm excitation and 516 nm emission wavelengths.
Statistical analysis
Data are expressed as a mean ± SD. Analysis of ANOVA variance with a Tukey post hoc test was used for multiple comparisons. All statistics were calculated using the STATISTICA program (StatSoft, Tulsa, OK, USA). A P value of \0.05 was considered significant.
Results
Cytotoxicity studies
The cytotoxic activity of hydrogen peroxide was determined by the MTT test after 24,48 and 72 h ( Table 1 [15, 19] . Table 2 presents, that pre-treatment of all type of cells with NAC (3 mM) or gliclazide (5-50 lM) followed by H 2 O 2 (50 lM) treatment improved cell viability by about 100%. Gliclazide used in the entire range of concentrations increased viability after exposure to hydrogen peroxide (200 lM) to 90% regardless of the type of cell line. 
Intracellular calcium ion concentration
To examine whether the intracellular calcium changes were involved in apoptosis induced by H 2 O 2 , we studied the level of calcium using the fluorescence probe Fluo-4-NW. Our results indicate that calcium level also depends on H 2 O 2 concentration, the time of incubation and the type of cells. Table 3 shows that in the tested cells H 2 O 2 induced a 
Discussion
It is well known that T2DM generally progresses over time and majority of diabetics previously well-metabolically controlled with sulfonylureas may require insulin replacement therapy. It has been suggested that exhaustion or desensitization of pancreatic b-cells by prolonged exposure to sulphonylureas and possibly acceleration of oxidative stress and apoptosis are major causes of secondary failure to these oral hypoglycemic medications. The association of glibenclamide with increased b-cell apoptosis in human islets has been demonstrated in vitro by Meadler et al. [25] . Clinical studies indicate that early insulin treatment in newly diagnosed T2DM patients preserved b-cell secretory function more effectively than glibenclamide [26] . Interestingly, a retrospective analysis performed by Satoh et al. found that patients treated with gliclazide required exogenous insulin support less frequently, than those treated with glibenclamide. These observations suggest that gliclazide but not glibenclamide may protect b-cells and thereby delay development of a secondary failure [27] . It is worth mentioning that gliclazide may protect against oxidative stress-related diabetic complications since a significantly lower mortality for cardiovascular diseases and malignancies was suggested in patients treated with gliclazide compared to other hypoglycaemic drugs, especially sulphonylureas [28] [29] [30] .
There are several mechanisms that may be responsible for b -cell mass loss and dysfunction associated with sulfonylureas use in diabetics. ROS overproduction and disequilibrium of Ca 2? homeostasis induced by sulfonylureas seem to be involved in these processes. It was demonstrated that glibenclamide, glimepiride and nateglinide stimulate ROS production in the pancreatic b-cell line MIN6 within the therapeutic concentration range in plasma of treated patients [12, 31] . Sawada et al. have found that these compounds-related ROS production was mediated by a PKC-dependent activation of NAD(P)H oxidase [12] . The secreatgogues raise the intracellular Ca 2? concentration by opening of voltage-operated Ca 2? channels and increasing Ca 2? influx [32] . Since Ca 2? plays an important [33, 34] .
In our experiments, we used H 2 O 2 which by generation of ROS increases an oxidative stress insult that may cause cells death [35] . Number of evidence indicates that H 2 O 2 / ROS activate K ATP ? channels and hyperpolarize the plasma membrane potential. It has been reported that an oxidative stress potentates the amount of ROS by stimulating mitochondrial ROS production. ROS are also able to trigger the opening of the mitochondrial permeability transition pore to an extent, that collapses the mitochondrial membrane potential and leads to ATP depletion [15, 36, 37] . Moreover, a reduction in the mitochondrial membrane potential (DW m ) results in the release of mitochondrial Ca 2? and a rise in cytosolic [Ca 2? ] and may also contribute to cell death [38, 39] .
As we expected, H 2 O 2 induced apoptosis in human normal and cancer cells since the cytotoxic effects of this molecule is well known [40] . The results of our study indicate that gliclazide reduced the number of H 2 O 2 -related necrotic and apoptotic cells. These findings are consistent with the earlier reports showing, that gliclazide attenuated apoptotic b-cell as well as endothelial cells death induced by an oxidative stress. As was suggested by others, we believe that this effect is most likely caused by free radical scavenging properties of gliclazide [15] [16] [17] [18] . It is worth underlying that these unique activities of the drug are not shared by other sulphonylureas [20, 41] . Recently, it has been reported that glibenclamide and glimepiride, but not gliclazide, significantly increased ROS production in b-cell [12] . It is suggested that several mechanisms may be responsible for these differences. Firstly, gliclazide possesses free radical scavenging activity. Secondly, the binding of gliclazide to SUR1 receptor is rapidly reversible in contrary to other sulphonylureas [10, 42] ] mediated via K ATP channels [15] . Interestingly, the results of our study may at least partially support these findings because we showed that gliclazide decreased the intracellular [Ca 2? ] in tested cell lines exposed to H 2 O 2 . Mitochondria are major intracellular source of reactive oxygen species and play an important role in apoptotic form of cell death [43] . As was mentioned earlier, ROS/H 2 O 2 cause depolarization of mitochondria and local Ca 2? release, what leads to loss of DW m , opening of mitochondrial permeability transition pore, damage to cell and finally cell death [39, 44] In summary, the results of our work provide an additional evidence that gliclazide may diminish oxidative stress-related cell damage and death. Gliclazide decreases ROS production, elevates DW m and diminishes intracellular [Ca 2? ] in human normal and cancer cells exposed to H 2 O 2 . However, further studies are needed to explore whether the same effect occurs in T2DM patients treated with this drug.
